Spread the love

Preclinical studies of an insulin candidate named NNC2215 have shown promise; this smart insulin can alter its own activity in response to glucose concentration in the body

​Preclinical studies of an insulin candidate named NNC2215 have shown promise; this smart insulin can alter its own activity in response to glucose concentration in the body  

By

Leave a Reply

Your email address will not be published. Required fields are marked *